• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝中药物代谢细胞色素 P450 酶和雌激素受体 α(ESR1)的共表达:种族差异和 ESR1 的调节作用。

Co-expression of drug metabolizing cytochrome P450 enzymes and estrogen receptor alpha (ESR1) in human liver: racial differences and the regulatory role of ESR1.

机构信息

Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.

出版信息

Drug Metab Pers Ther. 2021 Apr 7;36(3):205-214. doi: 10.1515/dmpt-2020-0160.

DOI:10.1515/dmpt-2020-0160
PMID:33823094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8376797/
Abstract

OBJECTIVES

The function and expression of cytochrome P450 (CYP) drug metabolizing enzymes is highly variable, greatly affecting drug exposure, and therapeutic outcomes. The expression of these enzymes is known to be controlled by many transcription factors (TFs), including ligand-free estrogen receptor alpha (ESR1, in the absence of estrogen). However, the relationship between the expression of ESR1, other TFs, and CYP enzymes in human liver is still unclear.

METHODS

Using real-time PCR, we quantified the mRNA levels of 12 CYP enzymes and nine TFs in 246 human liver samples from European American (EA, n = 133) and African American (AA, n = 113) donors.

RESULTS

Our results showed higher expression levels of ESR1 and six CYP enzymes in EA than in AA. Partial least square regression analysis showed that ESR1 is the top-ranking TF associating with the expression of eight CYP enzymes, six of which showed racial difference in expression. Conversely, four CYP enzymes without racial difference in expression did not have ESR1 as a top-ranking TF. These results indicate that ESR1 may contribute to variation in CYP enzyme expression between these two ancestral backgrounds.

CONCLUSIONS

These results are consistent with our previous study showing ESR1 as a master regulator for the expression of several CYP enzymes. Therefore, factors affecting ESR1 expression may have broad influence on drug metabolism through altered expression of CYP enzymes.

摘要

目的

细胞色素 P450(CYP)药物代谢酶的功能和表达具有高度可变性,极大地影响药物暴露和治疗效果。这些酶的表达已知受许多转录因子(TFs)的控制,包括无配体的雌激素受体 alpha(ESR1,在没有雌激素的情况下)。然而,人类肝脏中 ESR1、其他 TF 和 CYP 酶的表达之间的关系尚不清楚。

方法

我们使用实时 PCR 定量分析了来自欧洲裔美国人(EA,n = 133)和非裔美国人(AA,n = 113)供体的 246 个人肝样本中 12 种 CYP 酶和 9 种 TF 的 mRNA 水平。

结果

我们的结果表明,EA 中 ESR1 和六种 CYP 酶的表达水平高于 AA。偏最小二乘回归分析表明,ESR1 是与八种 CYP 酶表达相关的排名最高的 TF,其中六种 CYP 酶在表达上存在种族差异。相反,四种在表达上没有种族差异的 CYP 酶没有 ESR1 作为排名最高的 TF。这些结果表明,ESR1 可能导致这两个祖先后裔背景中 CYP 酶表达的差异。

结论

这些结果与我们之前的研究一致,表明 ESR1 是几种 CYP 酶表达的主要调节因子。因此,影响 ESR1 表达的因素可能通过改变 CYP 酶的表达对药物代谢产生广泛影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/dd971e59cb7f/nihms-1719439-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/e3a5370e4f7c/nihms-1719439-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/7749c08813e7/nihms-1719439-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/dd971e59cb7f/nihms-1719439-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/e3a5370e4f7c/nihms-1719439-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/7749c08813e7/nihms-1719439-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1f6/8376797/dd971e59cb7f/nihms-1719439-f0003.jpg

相似文献

1
Co-expression of drug metabolizing cytochrome P450 enzymes and estrogen receptor alpha (ESR1) in human liver: racial differences and the regulatory role of ESR1.人肝中药物代谢细胞色素 P450 酶和雌激素受体 α(ESR1)的共表达:种族差异和 ESR1 的调节作用。
Drug Metab Pers Ther. 2021 Apr 7;36(3):205-214. doi: 10.1515/dmpt-2020-0160.
2
Ligand-Free Estrogen Receptor (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver.配体非依赖型雌激素受体(ESR1)作为人肝中 CYP3A4 和其他细胞色素 P450 酶表达的主调控因子。
Mol Pharmacol. 2019 Oct;96(4):430-440. doi: 10.1124/mol.119.116897. Epub 2019 Aug 9.
3
Genome-wide microRNA profiles identify miR-107 as a top miRNA associating with expression of the CYP3As and other drug metabolizing cytochrome P450 enzymes in the liver.全基因组微小RNA谱分析确定miR-107是与肝脏中CYP3A及其他药物代谢细胞色素P450酶表达相关的首要微小RNA。
Front Pharmacol. 2022 Aug 17;13:943538. doi: 10.3389/fphar.2022.943538. eCollection 2022.
4
ESR1 ChIP-Seq Identifies Distinct Ligand-Free ESR1 Genomic Binding Sites in Human Hepatocytes and Liver Tissue.ESR1 ChIP-Seq 鉴定出人肝细胞和肝组织中独特的无配体 ESR1 基因组结合位点。
Int J Mol Sci. 2021 Feb 2;22(3):1461. doi: 10.3390/ijms22031461.
5
Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.人类细胞色素P450同工酶在汽油醚的代谢及健康影响中的作用
Res Rep Health Eff Inst. 2001 May(102):7-27; discussion 95-109.
6
Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.麻醉药物会改变雄性小鼠肝脏中细胞色素P450 2E1和2C6的表达以及其他致癌物代谢酶的活性。
Toxicology. 2003 Sep 30;191(2-3):133-42. doi: 10.1016/s0300-483x(03)00252-x.
7
Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes.细胞色素 P450 相关 miRNA 和转录因子在人肝脏中的表达变化:与细胞色素 P450 基因表型的相关性。
Toxicol Appl Pharmacol. 2021 Feb 1;412:115389. doi: 10.1016/j.taap.2020.115389. Epub 2020 Dec 30.
8
Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.参与西地那非N-去甲基化的细胞色素P450酶的鉴定。
Br J Clin Pharmacol. 2001 Mar;51(3):239-48. doi: 10.1046/j.1365-2125.2001.00318.x.
9
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.药物代谢细胞色素 P450 酶对治疗结果有多种影响。
Clin Pharmacokinet. 2021 May;60(5):585-601. doi: 10.1007/s40262-021-01001-5. Epub 2021 Mar 16.
10
Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression.雌激素-雌激素受体 α 信号通过调节细胞色素 P450 2A6 表达促进再生肝脏中胆红素代谢。
Cell Transplant. 2017 Nov;26(11):1822-1829. doi: 10.1177/0963689717738258.

引用本文的文献

1
Association Between UGT1A1 mRNA Expression and Cis-Acting Genetic Variants and Trans-Acting Transcriptional Regulators in Human Liver Samples.人肝脏样本中UGT1A1 mRNA表达与顺式作用基因变异及反式作用转录调节因子之间的关联
Genes (Basel). 2025 Aug 18;16(8):971. doi: 10.3390/genes16080971.
2
The Association Between Promoter Tandem Repeat Polymorphism (pVNTR) and CYP2C9 Gene Expression in Human Liver Samples.人肝脏样本中启动子串联重复多态性(pVNTR)与CYP2C9基因表达之间的关联
Genes (Basel). 2025 Feb 11;16(2):213. doi: 10.3390/genes16020213.
3
Hepatic Gene Expression and Metabolite Profiles of Androstenone and Skatole Relative to Plasma Estrone Sulfate Levels in Boars.

本文引用的文献

1
Highly Variable Expression of Splice Variants in Human Liver: Implication in the Liver Gene Expression Regulation and Inter-Person Variability in Drug Metabolism and Liver Related Diseases.人类肝脏中剪接变体的高度可变表达:对肝脏基因表达调控以及药物代谢和肝脏相关疾病个体间变异性的影响。
J Mol Genet Med. 2019;13(3). Epub 2019 Sep 30.
2
Racial and Ethnic Differences in Response to Anticoagulation: A Review of the Literature.种族和民族差异对抗凝治疗的反应:文献综述。
J Pharm Pract. 2021 Oct;34(5):685-693. doi: 10.1177/0897190019894142. Epub 2019 Dec 26.
3
Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms.
公猪血浆雌酮硫酸酯水平与雄甾酮和粪臭素的肝基因表达和代谢谱的关系。
Biomolecules. 2024 Jul 15;14(7):850. doi: 10.3390/biom14070850.
4
Pharmacokinetics, Pharmacodynamics, and Side Effects of Midazolam: A Review and Case Example.咪达唑仑的药代动力学、药效学及副作用:综述与病例示例
Pharmaceuticals (Basel). 2024 Apr 8;17(4):473. doi: 10.3390/ph17040473.
5
Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma.生物信息学和机器学习驱动的肝细胞癌关键基因筛选
Biochem Biophys Rep. 2023 Nov 25;37:101587. doi: 10.1016/j.bbrep.2023.101587. eCollection 2024 Mar.
6
Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.人组织中尿苷二磷酸葡萄糖醛酸基转移酶转录组的定量分析。
Pharmacol Res Perspect. 2023 Dec;11(6):e01154. doi: 10.1002/prp2.1154.
7
A frequent CYP2D6 variant promotes skipping of exon 3 and reduces CYP2D6 protein expression in human liver samples.一种常见的CYP2D6变体促使外显子3跳跃,并降低人肝脏样本中CYP2D6蛋白的表达。
Front Pharmacol. 2023 Jul 27;14:1186540. doi: 10.3389/fphar.2023.1186540. eCollection 2023.
8
A Comprehensive Evaluation of the Effects of RNA-Editing Proteins ADAR and ADARB1 on the Expression of the Drug-Metabolizing Enzymes in HepaRG Cells.全面评估 RNA 编辑蛋白 ADAR 和 ADARB1 对 HepaRG 细胞中药物代谢酶表达的影响。
Drug Metab Dispos. 2023 Nov;51(11):1508-1514. doi: 10.1124/dmd.123.001396. Epub 2023 Aug 2.
9
Metabolomics- and systems toxicology-based hepatotoxicity mechanism of in rats.基于代谢组学和系统毒理学的大鼠肝毒性机制
Front Pharmacol. 2022 Nov 18;13:1015008. doi: 10.3389/fphar.2022.1015008. eCollection 2022.
10
Genome-wide microRNA profiles identify miR-107 as a top miRNA associating with expression of the CYP3As and other drug metabolizing cytochrome P450 enzymes in the liver.全基因组微小RNA谱分析确定miR-107是与肝脏中CYP3A及其他药物代谢细胞色素P450酶表达相关的首要微小RNA。
Front Pharmacol. 2022 Aug 17;13:943538. doi: 10.3389/fphar.2022.943538. eCollection 2022.
迈向精准医学:探究人类基因组,以鉴定与潜在功能、人群分化多态性相关的药物途径。
Pharmacogenomics J. 2019 Dec;19(6):516-527. doi: 10.1038/s41397-019-0096-y. Epub 2019 Oct 3.
4
Ligand-Free Estrogen Receptor (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver.配体非依赖型雌激素受体(ESR1)作为人肝中 CYP3A4 和其他细胞色素 P450 酶表达的主调控因子。
Mol Pharmacol. 2019 Oct;96(4):430-440. doi: 10.1124/mol.119.116897. Epub 2019 Aug 9.
5
Clinical Importance of () Gene Polymorphisms and Their Expression Patterns in Coronary Artery Disease Patients: A Study from India.()基因多态性及其表达模式在冠状动脉疾病患者中的临床重要性:一项来自印度的研究
Indian J Clin Biochem. 2019 Apr;34(2):133-142. doi: 10.1007/s12291-019-00827-y. Epub 2019 Apr 5.
6
The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.非裔人群中华法林剂量反应变异性的遗传学:过去、现在和未来的专家观点。
OMICS. 2019 Mar;23(3):152-166. doi: 10.1089/omi.2019.0018.
7
Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China.雌激素受体1基因多态性与中国绝经后女性的代谢综合征相关。
BMC Endocr Disord. 2018 Sep 14;18(1):65. doi: 10.1186/s12902-018-0289-4.
8
Ten Years' Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics.CYP2D6活性评分十年经验:关于未来研究以改善精准治疗临床预测的展望
J Pers Med. 2018 Apr 17;8(2):15. doi: 10.3390/jpm8020015.
9
Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.氯胺酮及其代谢产物作为新型雌激素受体配体:诱导细胞色素 P450 和 AMPA 谷氨酸受体基因表达。
Biochem Pharmacol. 2018 Jun;152:279-292. doi: 10.1016/j.bcp.2018.03.032. Epub 2018 Apr 3.
10
Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression.雌激素-雌激素受体 α 信号通过调节细胞色素 P450 2A6 表达促进再生肝脏中胆红素代谢。
Cell Transplant. 2017 Nov;26(11):1822-1829. doi: 10.1177/0963689717738258.